In this episode, Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES, discusses data and recommendations for providing HIV prevention options as a strategy to support PrEP persistence and engagement, including: 

• Postexposure prophylaxis (PEP) recommendations and the data for PEP-in-Pocket
• Offering PrEP to everyone who receives PEP
• Currently recommended PrEP options and the safety and adverse event considerations with each option
• Monitoring recommendations for the different PrEP options
• The importance of proactively addressing PrEP safety concerns that could lead to PrEP discontinuation

Faculty

Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES
Assistant Professor
Pharmacotherapeutics and Clinical Research
University of South Florida Taneja College of Medicine
Tampa, Florida

Follow along with the slides:
bit.ly/48cULUN

Link to full program:
bit.ly/3ZlICsL